| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/27/2008 | EP1891017A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/27/2008 | EP1890703A2 Pyrimidine compounds |
| 02/27/2008 | EP1890697A2 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/27/2008 | EP1802307B1 Pyrrolidine derivatives as histamine receptors ligands |
| 02/27/2008 | EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 02/27/2008 | EP0896578B1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 02/27/2008 | CN101133051A Quinoxaline dihydrohalide dihydrates and synthetic methods thereof |
| 02/27/2008 | CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 02/27/2008 | CN101133035A Method for the production of losartan |
| 02/27/2008 | CN101130539A Indole-substituteing imidazoline-2-ketones derivant, preparing method and uses of the same |
| 02/27/2008 | CN101130521A Novel pyrimidine derivative with obvious biological activity |
| 02/27/2008 | CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 02/27/2008 | CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/26/2008 | US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335672 Vanilloid receptor ligands and their use in treatments |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335658 Pyridazine derivatives and their use as therapeutic agents |
| 02/26/2008 | US7335657 Cytokine inhibitors |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | CA2291094C 2-oxoimidazole derivative |
| 02/21/2008 | WO2008022013A1 Kinase inhibitors |
| 02/21/2008 | WO2008021928A2 Hepatitis c virus inhibitors |
| 02/21/2008 | WO2008021927A2 Hepatitis c virus inhibitors |
| 02/21/2008 | WO2008020606A1 Antiangiogenic agent |
| 02/21/2008 | WO2008020453A2 A process for the preparation of a novel crystalline polymorph of aripiprazole |
| 02/21/2008 | WO2008020302A2 Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
| 02/21/2008 | WO2008020229A2 Antibacterial pyrrolecarboxamides |
| 02/21/2008 | WO2008020227A2 Antibacterial pyrrolecarboxamides |
| 02/21/2008 | WO2007149448A3 Pyrazinones as cellular proliferation inhibitors |
| 02/21/2008 | WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 02/21/2008 | WO2007123855B1 Pyrazolines for controlling invertebrate pests |
| 02/21/2008 | WO2007101213A3 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | US20080045542 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy |
| 02/21/2008 | US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045506 Pyrrolidine Derivatives as Histamine Receptors Ligands |
| 02/21/2008 | US20080045505 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators |
| 02/21/2008 | US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080044881 Advanced Indolinone Based Protein Kinase Inhibitors |
| 02/21/2008 | US20080044380 Hepatitis C Virus Inhibitors |
| 02/21/2008 | CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 02/21/2008 | CA2660628A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2660560A1 Pyrazine compounds, their use and methods of preparation |
| 02/21/2008 | CA2660520A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2660474A1 Arylpiperazine derivatives and uses thereof |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1888707A1 New materials for organic electroluminescence devices |
| 02/20/2008 | EP1888572A1 Quinazolines and their use as aurora kinase inhibitors |
| 02/20/2008 | EP1888565A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 02/20/2008 | EP1888563A1 Proline bis-amide orexin receptor antagonists |
| 02/20/2008 | EP1888562A2 Dipeptidyl peptidase-iv inhibitors |
| 02/20/2008 | EP1888561A1 Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer |
| 02/20/2008 | EP1888560A1 Novel dipodazine compounds and applications |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888528A2 Phosphodiesterase 4 inhibitors |
| 02/20/2008 | EP1622620B1 Quinazoline derivatives and their use in the treatment of cancer |
| 02/20/2008 | EP1613312B1 Benzimidazole derivatives and their use for modulating the gaba a receptor complex |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1529034B1 Benzoylpyrazolones substituted by 3-aminocarbonyl |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | CN101128441A Fused aromatic compounds having anti-diabetic activity |
| 02/20/2008 | CN101128440A Hydrazinomethyl, hydr zonomethyl and 5-membered heterocyclic compounds which act as mTOR inhibitors and their use as anti cancer agents |
| 02/20/2008 | CN101128439A 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 02/20/2008 | CN101128432A Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 02/20/2008 | CN101126022A Bi-vinyl anthracenes luminescent compounds |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/19/2008 | US7332612 Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 02/19/2008 | US7332520 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2287557C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 02/19/2008 | CA2287556C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 02/19/2008 | CA2207100C Pyrimidine derivatives |
| 02/19/2008 | CA2113726C Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
| 02/14/2008 | WO2008019276A2 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use |
| 02/14/2008 | WO2008019124A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/14/2008 | WO2008018843A1 Process for producing useful salts form of biphenyl-tetrazole compounds |
| 02/14/2008 | WO2008018639A2 Glycine transporter inhibitor |